Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
59m
EMA支持艾伯维公司卵巢癌药物ELAHERE
伊利诺伊州北芝加哥 - 艾伯维公司(NYSE: ABBV)的药物mirvetuximab soravtansine (ELAHERE)获得了欧洲药品管理局(EMA)人用药品委员会(CHMP)的积极意见,用于治疗特定卵巢癌患者。该推荐适用于治疗叶酸受体α(FRα)阳性、铂类耐药、高级别浆液性上皮性卵巢癌、输卵管癌或原发性腹膜癌的成年患者,这些患者此前已接受过一到三种治疗方案。 CHMP的这一支持意见 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Kentucky judge fatally shot
Human remains found in SUV
Secret Service probing post
FCC chair denies Trump call
Cancels appearance w/ Duda
Boy kills bear, saves father
NYC subway joyride arrest
Ban called for in TX schools
To get a second moon
Families lose appeal
Man charged for threats
Hold campaign event in MI
Vows to remain in race
Collapse hazard recall
To visit US next week
PGA welcomes LIV players
Retires after 17 seasons
160M euros to Ukraine
FTC on privacy controls
Hails economic progress
Brazil threatens daily fines
Dow, S&P hit record highs
Gun case sentencing delay
Existing home sales drop
COVID, Wuhan market link
EU warns Apple
Overdose deaths drop in US
UN backs Palestine
Israel strikes Hezbollah
To receive Holbrooke award
Makes MLB history
Feedback